600252.SH
中恒集团
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 2.18
−1.80%Aug 31, 2026, 09:06 UTC
Zhongheng Group announced its first share repurchase of 4.7 million shares on August 31, 2026, with a cumulative repurchase amount of 10.851 million yuan, under a plan to repurchase 100-200 million yuan of shares to reduce registered capital.
Source:Aug 17, 2026, 11:04 UTC
Zhongheng Group's board approved extending the operating term of its consolidated partnership Guangxi Defu from June 30, 2026 to May 30, 2027, subject to partner meeting approval.
Source: